Grant: Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
University of Toronto
$100,000.00
Investigation of ion-coupled solute cotransport: Structure/function studies of the rabbit Na+/D-glucose cotransporter (SGLT1)
FY 2008-09
Summary
Our focus is a unique protein called SGLT1, expressed on the surface of cells in the intestine, kidney and lung. By an as yet unknown mechanism, SGLT1 transports in a tightly coupled fashion two Na+ ions and one sugar molecule, from the exterior into the cell.Recently, new structural information has been obtained for a bacterial protein vSGLT, which transpoprts one Na+ ion and one galactose sugar molecule. It is similar in many respects to the mammalian forms of SGLT1 and this information is important because it provides us with new insights--but the mechanism of how co-transport of Na+ and sugar is achiebved, remains unknown.
Our objective is to determine the fundamental molecular/atomic events that underlie the co-transport process. Our approach is to exploit SGLT1 as a model experimental system, with the objective of identifying general principles that are applicable across the entire family of ion coupled solute co-transporters.
In addition to the importance of the basic science question that is being addressed, SGLT1 has intrinsic interest in its own right. It is also very similar to SGLT2 which is the major transporter responsible for reabsorbing glucose in the kidney. The results of our research on SGLT1 are directly applicable to understanding the function of SGLT2. There is great interest in designing drugs that will block SGLT2 function and allow control of blood sugar in diabetes. Our research will open up new possibilities for drug design to inhibit SGLT2.
Department
Program
Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
178994
Name
Silverman Melvin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Cell Physiology
Projecttitle
Investigation of ion-coupled solute cotransport: Structure/function studies of the rabbit Na+/D-glucose cotransporter (SGLT1)
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Inst of Nutrition, Metabolism and Diabetes -Bridge Funding
Keyworddelim
Chemical Modification By Methanethiosulphonate Derivatives; Cos-7 Cell Expression; Cysteine Mutagenesis; Electrophysiology Using 2-Electrode Voltage Clamp; Fluorescence; Ion-Coupled Solute Cotransport; Isotope Uptake
Abstract
Our focus is a unique protein called SGLT1, expressed on the surface of cells in the intestine, kidney and lung. By an as yet unknown mechanism, SGLT1 transports in a tightly coupled fashion two Na+ ions and one sugar molecule, from the exterior into the cell.Recently, new structural information has been obtained for a bacterial protein vSGLT, which transpoprts one Na+ ion and one galactose sugar molecule. It is similar in many respects to the mammalian forms of SGLT1 and this information is important because it provides us with new insights--but the mechanism of how co-transport of Na+ and sugar is achiebved, remains unknown.
Our objective is to determine the fundamental molecular/atomic events that underlie the co-transport process. Our approach is to exploit SGLT1 as a model experimental system, with the objective of identifying general principles that are applicable across the entire family of ion coupled solute co-transporters.
In addition to the importance of the basic science question that is being addressed, SGLT1 has intrinsic interest in its own right. It is also very similar to SGLT2 which is the major transporter responsible for reabsorbing glucose in the kidney. The results of our research on SGLT1 are directly applicable to understanding the function of SGLT2. There is great interest in designing drugs that will block SGLT2 function and allow control of blood sugar in diabetes. Our research will open up new possibilities for drug design to inhibit SGLT2.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silverman, Melvin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~